Springbok Capital Management »

Miragen Therapeutics shares owned by Springbok Capital Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Springbok Capital Management from 13F filings

Historical chart of Springbok Capital Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Springbok Capital Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $243k 17k 13.98
2025-03-31 $912k 68k 13.48
2024-09-30 $1.2M 51k 22.75